HK1175994A1 - 丹參組合物在製備用於冠心病二級預防的藥物中的用途 - Google Patents

丹參組合物在製備用於冠心病二級預防的藥物中的用途

Info

Publication number
HK1175994A1
HK1175994A1 HK13103083.7A HK13103083A HK1175994A1 HK 1175994 A1 HK1175994 A1 HK 1175994A1 HK 13103083 A HK13103083 A HK 13103083A HK 1175994 A1 HK1175994 A1 HK 1175994A1
Authority
HK
Hong Kong
Prior art keywords
heart disease
coronary heart
salvia miltiorrhiza
secondary prevention
preparing drugs
Prior art date
Application number
HK13103083.7A
Other languages
English (en)
Inventor
閆希軍
吳迺峰
閆凱境
孫鶴
郭治昕
祝國光
劉巍巍
趙利斌
羅瑞芝
Original Assignee
天士力製藥集團股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 天士力製藥集團股份有限公司 filed Critical 天士力製藥集團股份有限公司
Publication of HK1175994A1 publication Critical patent/HK1175994A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK13103083.7A 2010-08-06 2013-03-12 丹參組合物在製備用於冠心病二級預防的藥物中的用途 HK1175994A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201010253344 2010-08-06
PCT/CN2011/078128 WO2012016549A1 (zh) 2010-08-06 2011-08-08 丹参组合物在制备用于冠心病二级预防的药物中的用途

Publications (1)

Publication Number Publication Date
HK1175994A1 true HK1175994A1 (zh) 2013-07-19

Family

ID=45558949

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13103083.7A HK1175994A1 (zh) 2010-08-06 2013-03-12 丹參組合物在製備用於冠心病二級預防的藥物中的用途

Country Status (17)

Country Link
US (1) US9072745B2 (zh)
EP (1) EP2601958B1 (zh)
JP (2) JP6030556B2 (zh)
KR (2) KR20130073938A (zh)
CN (1) CN103068398B (zh)
AU (1) AU2011288044B8 (zh)
BR (1) BR112013002814B1 (zh)
CA (1) CA2807283C (zh)
DK (1) DK2601958T3 (zh)
EA (1) EA025307B1 (zh)
ES (1) ES2624285T3 (zh)
HK (1) HK1175994A1 (zh)
MX (1) MX353834B (zh)
MY (1) MY160768A (zh)
NZ (1) NZ606595A (zh)
SG (1) SG187715A1 (zh)
WO (1) WO2012016549A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110025830A1 (en) 2009-07-31 2011-02-03 3Dmedia Corporation Methods, systems, and computer-readable storage media for generating stereoscopic content via depth map creation
US8508580B2 (en) 2009-07-31 2013-08-13 3Dmedia Corporation Methods, systems, and computer-readable storage media for creating three-dimensional (3D) images of a scene
AU2011288044B8 (en) * 2010-08-06 2014-08-07 Tasly Pharmaceutical Group Co., Ltd. Use of Salvia miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease
US8274552B2 (en) 2010-12-27 2012-09-25 3Dmedia Corporation Primary and auxiliary image capture devices for image processing and related methods
ES2869918T3 (es) 2013-07-11 2021-10-26 Tasly Pharmaceutical Group Co Método de preparación de una píldora de microgota de medicina tradicional china y píldora de microgota de medicina tradicional china preparada usando el método
GEP20186877B (en) 2013-07-11 2018-07-10 Tasly Pharmaceutical Group Co Traditional chinese medicine composition, and preparation and application thereof
EP3020407A4 (en) 2013-07-11 2017-05-03 Tasly Pharmaceutical Group Co., Ltd. Traditional chinese medicine composition, and preparation and application thereof
CN104418744B (zh) 2013-08-29 2017-03-01 天士力制药集团股份有限公司 一种新的丹酚酸化合物t、其制备方法和用途
CN104435525A (zh) * 2014-09-01 2015-03-25 周风华 防治细菌性心内膜炎的中药组合物及其制备方法
CN104800520A (zh) * 2015-04-16 2015-07-29 刘瑜 治疗心、小肠病症的红色中药包
CN104840900A (zh) * 2015-06-08 2015-08-19 刘云平 一种治疗心悸的中药
JP6520510B2 (ja) * 2015-07-15 2019-05-29 富士ゼロックス株式会社 情報処理装置及び情報処理プログラム
CN104998216A (zh) * 2015-08-19 2015-10-28 鄢明亮 一种用于预防治疗心悸的中药袋泡茶及制备方法
CN107137665B (zh) * 2017-06-02 2020-11-24 烟台大学 一种防治心肌纤维化的中药组合物及其应用
CN107714857A (zh) * 2017-12-01 2018-02-23 王章琳 一种治疗心脑血管病的中药组合物及其制备方法
KR102127706B1 (ko) * 2018-08-29 2020-06-29 윤화순 복합 한방 생약 추출물을 포함하는 혈행 개선용 제제
KR102127726B1 (ko) * 2018-08-29 2020-06-29 윤화순 복합 한방 생약 추출물을 포함하는 혈행 개선용 제제
CN111297942A (zh) * 2019-12-23 2020-06-19 卓和药业集团有限公司 一种治疗心肌缺血的复方制剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1456323A (en) * 1974-06-06 1976-11-24 Labaz Benzothiophenes process for preparing them and pharmaceutical compositions containing the same
KR100374416B1 (ko) * 2000-11-14 2003-03-04 노용일 고지혈증 및 협심증 예방 및 치료용 생약조성물
CA2434050C (en) * 2000-12-22 2014-09-16 Tianjin Tasly Pharmaceutical Co., Ltd., China Herbal composition for angina pectoris, method to prepare same and uses thereof
US8486464B2 (en) * 2000-12-22 2013-07-16 Tasly Pharmaceutical Group Co. Ltd. Herbal composition for angina pectoris, method to prepare same and uses thereof
CN1161140C (zh) * 2001-11-09 2004-08-11 天津天士力制药股份有限公司 一种预防和治疗冠心病心绞痛的药物及其制备方法和其它用途
CN1202103C (zh) * 2002-05-23 2005-05-18 天津天士力制药股份有限公司 丹参总酚酸的制备方法
CN100339085C (zh) * 2003-09-23 2007-09-26 天津天士力制药股份有限公司 治疗心脑血管疾病的中药组合物
CN100450501C (zh) * 2004-03-17 2009-01-14 天津天士力制药股份有限公司 一种治疗心脑血管疾病的中药制剂及其制备方法
CN100404041C (zh) * 2004-06-30 2008-07-23 天津天士力制药股份有限公司 一种治疗冠心病的药物组合物
CN1785249B (zh) 2004-12-06 2011-03-23 天津天士力制药股份有限公司 一种含有丹参的药物组合物的新用途
CN1919248B (zh) * 2005-08-24 2011-04-27 天津天士力制药股份有限公司 一种治疗心脑血管病的中药制剂
AU2011288044B8 (en) * 2010-08-06 2014-08-07 Tasly Pharmaceutical Group Co., Ltd. Use of Salvia miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease

Also Published As

Publication number Publication date
EA201300159A1 (ru) 2013-11-29
CA2807283C (en) 2019-05-14
CN103068398B (zh) 2015-08-19
AU2011288044B8 (en) 2014-08-07
JP2013533292A (ja) 2013-08-22
WO2012016549A1 (zh) 2012-02-09
AU2011288044A8 (en) 2014-08-07
EP2601958B1 (en) 2017-03-29
MX353834B (es) 2018-01-31
ES2624285T3 (es) 2017-07-13
KR20150107902A (ko) 2015-09-23
JP6030556B2 (ja) 2016-11-24
AU2011288044B2 (en) 2014-07-17
CN103068398A (zh) 2013-04-24
BR112013002814B1 (pt) 2020-10-27
KR20130073938A (ko) 2013-07-03
MY160768A (en) 2017-03-15
EA201300159A8 (ru) 2014-11-28
US20130196005A1 (en) 2013-08-01
JP2016183201A (ja) 2016-10-20
AU2011288044A1 (en) 2013-02-21
MX2013001298A (es) 2013-03-08
EP2601958A1 (en) 2013-06-12
DK2601958T3 (en) 2017-07-17
CA2807283A1 (en) 2012-02-09
EA025307B1 (ru) 2016-12-30
BR112013002814A2 (pt) 2018-02-06
NZ606595A (en) 2014-08-29
EP2601958A4 (en) 2013-12-18
SG187715A1 (en) 2013-03-28
US9072745B2 (en) 2015-07-07

Similar Documents

Publication Publication Date Title
HK1175994A1 (zh) 丹參組合物在製備用於冠心病二級預防的藥物中的用途
IL253000B (en) Tricyclic pyrazolyl compounds, their use for the preparation of drugs for the treatment of cancer and pharmaceutical preparations containing them
IL223783B (en) Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine
HK1208801A1 (zh) 口服給藥用藥物組合物
HK1163500A1 (zh) 治療心臟疾病之藥品配方
EP2621588A4 (en) METHODS AND COMPOSITIONS FOR TREATING DISEASE USING INHALATION
PT2482812T (pt) Composições farmacêuticas compreendendo bi-1356 e metformina
IL222268A (en) Preserved pyrollo-pyridines, containing pharmaceutical preparations, combined preparations containing them and their use in the preparation of medicines
ZA201300685B (en) Anticancer derivatives,preparation thereof and therapeutic use thereof
IL215065A (en) Proline derivatives, their preparation process, their pharmaceutical compositions and their uses in drug preparation
IL221744A (en) Use of a combination of compounds to prepare a drug to treat Parkinson's disease
HU1000069D0 (en) New salts for the preparation of pharmaceutical composition
HUE053977T2 (hu) Szilárd gyógyszer színezõanyagok orális alkalmazására és diagnosztikai felhasználásra
EP2514415A4 (en) TRANSDERMALLY ABSORBED PREPARATION OF ANTI-DEMENTIA MEDICINE
IL223872A (en) Pyrazoloquinoline derivatives and intermediates, process for preparation, use and pharmaceutical preparations and preparations containing them
HK1183228A1 (zh) 口服藥物治療方法和組合物
EP2709642A4 (en) THERAPEUTIC COMPOSITIONS OF CERTAIN HERBAL FORMULATIONS AND USES THEREOF
IL226471A0 (en) Using dronedrone to prepare a drug for use in managing the risk of liver injury
ZA201302012B (en) Low dose pharmaceutical composition
GB2495651B (en) A novel herbal formulation advocated for the prevention and management of coronary heart disease
IL218230B (en) Use of lapatinib or an acceptable pharmaceutical salt or preparation thereof for the preparation of a drug for the treatment of cancer
PT2603238E (pt) Métodos e composições farmacêuticas para o tratamento de uma doença ocular num indíviduo
EP2514416A4 (en) TRANSDERMAL ABSORBENT ANTI-DENSITY-AGENT PREPARATION
IL200753A (en) Pharmaceutical preparation containing ib – meca for the treatment of psoriasis
IL238071B (en) Pharmaceutical composition of 1-adamantylethyloxy-3-morpholino-2-propanol or pharmaceutically acceptable salts thereof for the treatment of cardiovascular disease